Press Releases

Press Releases

July 27, 2020
Company’s ultra-sensitive Simoa® technology powers more than 50 posters and presentations on display during this year’s virtual program; attendees can be among the first to experience Simoa p-tau181 assay for improved study of Alzheimer’s disease and visit virtual exhibitor booth
July 20, 2020
Findings from newly published research demonstrate promise of ultra-sensitive biomarker technology to identify and define high-risk populations through quantification of interferon (IFN) type I
June 11, 2020
BILLERICA, Mass.--(BUSINESS WIRE)--
May 29, 2020
Preliminary research demonstrates the biomarker’s revolutionary potential to empower accessible and scalable blood testing for Alzheimer’s disease; Quanterix to discuss latest findings and how researchers can gain early access to newest Simoa assay during June 3 PPH we
May 13, 2020
New research published in Lab on a Chip demonstrates 100x sensitivity improvement on Simoa; marks significant advancement in sensitivity for industry leading detection platform

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more